Abstract
New carboxamide head group analogs of thieno[3,2-b]pyridine-based kinase inhibitor LCRF-0004 were designed and synthesized. Potent and selective inhibitors of RON enzyme versus c-Met RTK were obtained.
Keywords:
Head group; Oncology; RON; RTK inhibitors; Thieno[3,2-b]pyridine scaffold; c-Met.
Copyright © 2015 Elsevier Ltd. All rights reserved.
MeSH terms
-
Amides / chemistry
-
Binding Sites
-
Drug Design*
-
Heterocyclic Compounds, 2-Ring / chemical synthesis*
-
Heterocyclic Compounds, 2-Ring / chemistry
-
Humans
-
Molecular Docking Simulation
-
Protein Binding
-
Protein Kinase Inhibitors / chemical synthesis*
-
Protein Kinase Inhibitors / chemistry
-
Protein Kinase Inhibitors / metabolism
-
Protein Structure, Tertiary
-
Proto-Oncogene Proteins c-met / antagonists & inhibitors
-
Proto-Oncogene Proteins c-met / metabolism
-
Pyrazoles / chemical synthesis*
-
Pyrazoles / chemistry
-
Receptor Protein-Tyrosine Kinases / antagonists & inhibitors*
-
Receptor Protein-Tyrosine Kinases / metabolism
Substances
-
Amides
-
Heterocyclic Compounds, 2-Ring
-
LCRF-0004
-
Protein Kinase Inhibitors
-
Pyrazoles
-
Proto-Oncogene Proteins c-met
-
RON protein
-
Receptor Protein-Tyrosine Kinases